Who invested in Merus?
Merus's investors include Novartis Venture Fund, Pfizer, Bay City Capital, EQT life science and Sofinnova Investments, and 8 more on record.
Netherlands · Series C startup
3 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$149Mraised across 3 rounds since 2010, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Reported by finsmes.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Merus's investors include Novartis Venture Fund, Pfizer, Bay City Capital, EQT life science and Sofinnova Investments, and 8 more on record.
Merus has raised $149M across 3 rounds since 2010.
Merus's most recent round was a Series C of $79M in Apr 2015.
Its most recent round, $79M in Apr 2015, is also its largest on record.
Merus's first round on record, in Jan 2010, was backed by Novartis Venture Fund, Pfizer and Bay City Capital and 1 others.
Merus's latest named round is a Series C, in Apr 2015.
Merus is based in the Netherlands.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.